FDA Additional Information (AI) & EU Notified Body Biocompatibility Response Pack
Help medical-device teams convert FDA and EU notified-body biocompatibility questions into controlled, evidence-linked response records without conflating review routes, clocks, or decision authority.
Package at a glance
11 ZIP entries
The current customer archive passed exact-inventory, checksum, and deterministic-rebuild QA.
18 workbook sheets
A fail-closed working system with sample content kept separate.
3-page Quick Start
A concise route through the files, controls, and escalation points.
16 official sources
Source status, limitations, retrieval dates, and recheck triggers.
A traceable working record—not a shortcut to a conclusion
Deficiency decomposition, evidence traceability, response drafting, clock control, and qualified-review handoff
Controlled Case & Route
A controlled case record that preserves the exact communication, route, submission or certificate identity, device version, dates, and accountable owners.
Verbatim Deficiency Register
A verbatim deficiency register with stable response IDs, requested outputs, rationale, route, dependencies, and explicit ambiguity flags.
Response Architecture
A response architecture that separates facts, evidence, analysis, commitments, proposed wording, and qualified decisions for each question.
Evidence & Locator Map
An evidence and locator map linking every response statement to controlled reports, pages, tables, figures, versions, and applicability limits.
What the current customer edition contains
The verified v3.0 archive contains 9 buyer payload files plus MANIFEST.csv and SHA-256 checksums. Final document, workbook, visual, and archive-integrity QA are complete.
Quick Start PDF
Set up the case, separate the review route, and identify immediate stop conditions.
Complete when: The team knows the exact case, current clock, file set, owners, and first controlled action.
Implementation Guide PDF
Apply a disciplined response method for FDA and EU notified-body biocompatibility questions.
Complete when: The route, evidence logic, response anatomy, limitations, and review boundary can be explained clearly.
Editable Working Templates DOCX
Draft intake, deficiency, evidence, response, commitment, QC, and approval records.
Complete when: All example and blank fields are replaced by controlled case-specific content.
Operational Workbook XLSX
Control questions, evidence, route, drafting, attachments, actions, review, and status.
Complete when: Every seeded assessment and red flag has a complete companion record and no unresolved stop condition is hidden.
Source Status and Release Notes PDF
Verify source dates, regulatory distinctions, recognition limits, and recheck triggers.
Complete when: The source register matches the exact rules and public authorities used for the response method.
README, responsible-use terms, manifest, and checksums
Orient the recipient, preserve package integrity, and control authorized use.
Complete when: Product identity, version, inventory, hashes, support route, and use boundary agree.
Inspect the actual working system
These are direct renders of the current v3.0 workbook prepared as public product views, not marketing mock-ups. Select any image to inspect it at full size.
How the resource is intended to be used
The complete Quick Start and implementation guide are included in the current v3.0 customer edition. This public walkthrough lets a buyer inspect the operating logic and stop conditions before requesting an exact offer.
Controlled case record
Capture the exact incoming communication and freeze the case identity before drafting.
Stop if: The communication, route, device, submission or certificate, date, sender, or complete attachment set is missing.
Route and clock record
Classify each item using the route stated in the communication, without converting FDA and EU processes into one generic deficiency workflow.
Stop if: The route, governing communication, contractual due date, clock effect, or submission channel is uncertain.
Deficiency register
Transcribe every question verbatim, assign a stable ID, and decompose it into requested facts, evidence, analysis, and decisions.
Stop if: A compound question, preamble, rationale, or requested deliverable would be lost through paraphrase.
Response scope baseline
Freeze the device, claims, intended use, final finished state, evidence cut-off, and submission or technical-document versions addressed by the response.
Stop if: The response could silently mix versions, variants, markets, evidence cuts, or post-question changes.
Evidence and applicability map
Map each proposed statement to controlled evidence and verify the report, test article, method, result, limitation, and current-device applicability.
Stop if: A statement depends on a summary, missing report, unverified locator, or unresolved representativeness gap.
FDA or EU response matrix
Draft route-specific responses using a direct answer, supporting evidence, analysis, limitation, commitment, and exact attachment or technical-file location.
Stop if: The response is argumentative, incomplete, inconsistent with source files, or promises work without an owner and date.
Controlled response candidate
Run cross-file identity, claim, number, version, locator, confidentiality, and change-propagation checks.
Stop if: The cover record, matrix, attachments, workbook, and changed technical documents disagree.
Qualified-review handoff
Obtain named biological-safety, toxicology, laboratory, regulatory, quality, and authorized sign-off as applicable, then hand off through the verified channel.
Stop if: A material question, red flag, source check, commitment, approval, or delivery instruction remains unresolved.
Current public authorities behind the working controls
Sources were checked 2026-08-02; next planned portfolio recheck is 2026-11-02. Live status must still be verified at each material decision or submission event.
FDA · 510(k) Submission Process
Current public process page. It distinguishes acceptance, substantive, Interactive Review, and Additional Information stages and states the 180-calendar-day complete-response condition for a 510(k) AI request.
FDA · Developing and Responding to Deficiencies in Accordance with the Least Burdensome Provisions
Final guidance, October 2022. Use its suggested deficiency and response structure with the exact application and current communication.
FDA · Types of Communication During the Review of Medical Device Submissions
Final guidance, April 2014. Formal communications and Interactive Review are distinct; apply the current program and the case communication.
FDA · FDA and Industry Actions on 510(k) Submissions: Effect on FDA Review Clock and Goals
Final guidance issued October 3, 2022. Consult the current submission record; the toolkit does not calculate an official FDA review clock.
FDA · eSTAR Program
Live program page. At the source check, nIVD eSTAR 7.0 is updated and 6.2 retires 2026-08-03; an acknowledged original submission keeps its eSTAR lineage for AI or Technical Screening responses.
FDA · Content of a 510(k)
Current public overview. Use product-specific guidance, special controls, applicable regulations, and the live submission template in addition to this general resource.
What the resource deliberately does not promise
Clear boundaries protect the buyer and make the working records more useful to qualified reviewers.
Clear boundary 1
No interpretation of a specific FDA or notified-body communication, contract, route, clock, or deadline.
Clear boundary 2
No automated test selection, endpoint applicability, toxicological acceptability, biological-safety, substantial-equivalence, conformity, or acceptance determination.
Clear boundary 3
No universal response language and no guarantee that a prior answer or evidence set applies to a changed device or different reviewer question.
Clear boundary 4
No reproduction of ISO standards or replacement for lawfully obtained standards, current regulator instructions, and the exact submission or certification record.
Questions to settle before requesting an offer
Is the current v3.0 edition available?
Yes. The current v3.0 customer edition is released and available by request. Online checkout, payment, customer download, and automatic delivery are not currently enabled. Use Request Exact Offer to receive the controlled offer before deciding whether to pay.
What is included in the current v3.0 edition?
The verified archive contains 11 ZIP entries: 9 buyer payload files plus MANIFEST.csv and SHA-256 checksums. It includes a 3-page Quick Start, 20-page implementation guide, 12-page editable templates, and 18-sheet workbook. Final document, workbook, visual, and archive-integrity QA are complete.
Does the resource provide a completed regulatory or biological conclusion?
No. It provides a traceable working system. Device-specific conclusions, testing decisions, toxicological judgments, and submission decisions require qualified review.
Can I inspect the product before requesting an offer?
Yes. This page shows the complete workflow and real v3.0 product views, while the downloadable 5-page public preview explains the scope, operating logic, included files, and important limits.
How to Respond to an FDA Biocompatibility AI Request
Understand why a defensible response closes the underlying evidence gap instead of answering the regulator question in isolation.
Review the workflow now. Request the exact current offer.
No order, payment, customer download, or delivery is created through this page. The controlled offer identifies the exact version, licence, price, update option, policies, and delivery method for your review before any payment decision.